Christopher Rivera
Direktor/Vorstandsmitglied bei HAPBEE TECHNOLOGIES, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Christopher Rivera
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HAPBEE TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 16.02.2022 | - |
Vorsitzender | 03.01.2019 | 16.02.2022 | |
Präsident | 03.01.2019 | - | |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Vorsitzender | 01.01.2016 | - |
Vorstandsvorsitzender | 01.01.2016 | - | |
Präsident | 01.01.2016 | - | |
Direktor/Vorstandsmitglied | 01.01.2014 | 01.01.2016 | |
CV6 Therapeutics (NI) Ltd.
CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology CV6 Therapeutics (NI) Ltd. develops and manufactures pharmaceutical drugs. The company is based in Belfast, UK. The British company was founded in 2013 by Robert D. Ladner, Karl A. Mulligan. Robert D. Ladner has been the CEO since 2013. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 05.04.2023 | - |
Karriereverlauf von Christopher Rivera
Ehemalige bekannte Positionen von Christopher Rivera
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HYPERION THERAPEUTICS INC | Vorstandsvorsitzender | 01.11.2006 | 01.01.2015 |
Gründer | 01.11.2006 | 01.01.2015 | |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Geschäftsführer | 01.04.2005 | 01.08.2006 |
Washington Biotechnology & Biomedical Association | Vorstandsvorsitzender | - | - |
Präsident | - | - | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - | - |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - | - |
Ausbildung von Christopher Rivera
Northwestern Oklahoma State University | Undergraduate Degree |
University of Oklahoma | Graduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Kanada | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 4 |
Chief Executive Officer | 3 |
President | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
Private Unternehmen | 8 |
---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Otonexus Medical Technologies, Inc.
Otonexus Medical Technologies, Inc. Medical SpecialtiesHealth Technology Otonexus Medical Technologies, Inc. is a holding company engages in health care industry. The firm designs, develops, and commercializes an ultrasound medical device that diagnoses middle ear infections in children and adults. The company was founded by Gerge A. Gates and Mark A. Moehring and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
CV6 Therapeutics (NI) Ltd.
CV6 Therapeutics (NI) Ltd. Pharmaceuticals: MajorHealth Technology CV6 Therapeutics (NI) Ltd. develops and manufactures pharmaceutical drugs. The company is based in Belfast, UK. The British company was founded in 2013 by Robert D. Ladner, Karl A. Mulligan. Robert D. Ladner has been the CEO since 2013. | Health Technology |
- Börse
- Insiders
- Christopher Rivera
- Erfahrung